Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
S

UPenn Expert Discussion on Lymphoma: Efficacy of Acalabrutinib for Severe COVID-19, Time-Limited Venetoclax / Obinutuzumab, Brentuximab Mono in HL

By Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient FEATURING Stephen Schuster, James Gerson, Jakub Svoboda, Elise Chong, Sunita D. Nasta, Douglas Beach, Gamil Hanna
By Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient FEATURING Stephen Schuster, James Gerson, Jakub Svoboda, Elise Chong, Sunita D. Nasta, Douglas Beach, Gamil Hanna
102 views
March 3, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

The First Treatment Choice Matters

Feat. A. Ip

Featured Video

18:30
Pfizer Hematology

Expert Case Review: A Treatment Option for Adult Patients With Stage…

Feat. A. Whiteley

Related Videos

08:18

Treatment Strategies for Hematocrit Control in PV

Insights from 2023 ASH Annual Meeting

A. Zhou

908 views
15:14

Safety Profile of Ruxolitinib in Patients With MF

Icahn School of Medicine at Mount Sinai

D. Tremblay

866 views
14:38

Top Risk Factors for Cancer by Sex and What to Do About It

MedCram

R. Seheult

159 views
09:27

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

ASH 2022 Conference Coverage

M. McMullin

1.1K views
06:51

Prevalence and Prediction of Ruxolitinib Treatment Emergent Thromboc…

Insights from 2023 ASH Annual Meeting

D. Tremblay

433 views
16:25

Diagnosis and Goals of Therapy in PV

Northwestern Medicine Oncology and Hematology

B. Stein

819 views
10:49

Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…

Monia Marchetti

403 views
13:04

Treatment-Related Quality of Life in MF

Winship Cancer Institute - Emory University

A. Hunter

286 views
18:30
Pfizer Hematology

Expert Case Review: A Treatment Option for Adult Patients With Stage…

Feat. A. Whiteley
19:39
Pfizer Hematology

Making the First Chance Count: Manuel

Feat. A. Ip
05:24

2021 ASCO Key Takeaways on Lymphoma: Selected Trials on CLL & HL, CA…

2021 ASCO Virtual Direct™ Highlights

M. Kamdar

202 views
01:24

ASCO 2022 Updates in Lymphoma and CLL

Total Health

W. Hammond

33 views
07:31

ASH Updates on cHL: 2L Pembro + GVD, Brentuximab Vedotin & Checkpoin…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

P. Riedell

121 views
16:42

Brentuximab Vedotin + AVD vs. ABVD in Advanced cHL: What Is the 5-Ye…

David Straus

94 views
08:30

Treatment Strategies for Advanced cHL: Predictive & Prognostic Marke…

i3 Health

K. Maddocks, K. Brassil

58 views
11:25

SOHO 2021 Next Questions in Hodgkin Lymphoma

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

C. Moskowitz

31 views
17:34

ASCO 2021 Q&A Session on Key Clinical Data in Leukemia & Lymphoma

2021 ASCO Virtual Direct™ Highlights

C. McMahon, M. Kamdar

56 views
38:27

Classical Hodgkin Lymphoma: Subtypes and Differential Diagnosis

Judith Ann Ferry

96 views
32:02

ASCO 2021 Q&A Session on New Updates in Hematologic Malignancies

2021 ASCO Virtual Direct™ Highlights

D. Maloney, M. Percival

26 views
19:53

Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL): Clinical an…

Judith Ann Ferry

116 views
AUTOPLAY